Proceedings from the sixth annual Mantle Cell Lymphoma (MCL) Consortium Scientific Workshop, which included 17 oral presentations, have been published in the March 2010 issue of the journal Leukemia & Lymphoma. Ordinarily not available to the public, a copy of this report can be found for one month on the journal’s Web site. Presentations were on topics such as biology of MCL, prognostic markers, new molecular targets, chemoimmunotherapy, transplantation, cellular therapy and novel therapeutic approaches. The aim of this workshop, held in March 2009, was to accelerate advances made in the field of MCL by creating a forum in which to share data, exchange ideas, foster collaboration within the MCL research community and identify and prioritize areas of clinical and translational research that will have the largest impact. “It is gratifying to see our work recognized by a respected scientific journal such as Leukemia & Lymphoma. We hope the information published in this report will further accelerate the understanding of mantle cell lymphoma and encourage other researchers to seek out collaborative work environments such as LRF’s Mantle Cell Lymphoma Consortium,” said Michael Williams, MD, MCLC Chairman and Director, Hematologic Malignancy Program – Hematology/Oncology Division University of Virginia Health System, Charlottesville. The next MCL Scientific Workshop will be held in Atlanta, GA March 24-25, 2010. To read the full press article in Leukemia & Lymphoma, click here. To read LRF’s press release about the article, click here. February 8, 2010